Answers are grounded in this paper and cite their sources.
T1 colorectal cancer (CRC) can be selectively treated with endoscopic local resection (LR) or surgical resection (SR) by pathologic evaluation of lymph node metastasis (LNM) risk.1–5 In previous studies, LNM frequency was 10%–15% in patients with high-risk lesions.6,7 Consequently, other risk factors require clarification for refined stratification. Regarding lesion location, patients with high-risk T1 rectal cancer have been found to have higher recurrence risk than those with colon lesions in other locations after LR alone.
No takes yet. Share an insight, caveat, or question.
Minamide et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: